What is the current stock price of CVRx, Inc. (CVRX)?

As of the latest market data, CVRx, Inc. (CVRX) is trading at $7.16. The stock has seen a loss of -4.34% today.

Does CVRx, Inc. (CVRX) pay a dividend?

Based on current data, CVRx, Inc. does not have a confirmed active dividend policy.

What is the market cap of CVRx, Inc.?

The current market capitalization of CVRx, Inc. (CVRX) is approximately unavailable.

CVRX

CVRx, Inc.·Healthcare

7.16

4.345%(−0.33)

Market Closed

7.16

0.070%(+0.00)

After Hours

Last Updated: — ET

52W L: $4.3052W H: $11.30

CVRX NEWS

globenewswire.com

2d ago

CVRx, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, April 09, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises CVRx , Inc , (“ CVRx " or the "Company") ( NASDAQ : CVRX ) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

defenseworld.net

Apr 1

Reviewing Orthofix Medical (NASDAQ:OFIX) and CVRx (NASDAQ:CVRX)

Orthofix Medical (NASDAQ: OFIX - Get Free Report) and CVRx (NASDAQ: CVRX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends. Volatility and Risk Orthofix Medical has a beta

businesswire.com

Mar 17

Securities Fraud Investigation Into CVRx, Inc. (CVRX) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CVRX, INC. (CVRX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On April 7, 2025, CVRx announced first quarter re.

businesswire.com

Mar 17

Securities Fraud Investigation Into CVRx, Inc. (CVRX) Continues – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CVRX, INC. (CVRX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is the Investigation About? On April 7, 2025, CVRx announced first quarter results, including revenue of only $12.

businesswire.com

Mar 17

CVRx, Inc. (CVRX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CVRX, INC. (CVRX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@.

globenewswire.com

Mar 3

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Company Profile

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Sector

Healthcare

Industry

Medical - Devices

Employees

206

IPO Date

2021-06-30

Beta

1.12

Websitewww.cvrx.com↗